Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement
Bindia Jharap(Meander Medisch Centrum), Dirk P. van Asseldonk(Noordwest Ziekenhuisgroep), Adriaan A. van Bodegraven(Zuyderland Medisch Centrum), Walter Reinisch(Medical University of Vienna), Jean‐Frédéric Colombel(Mount Sinai Hospital), Joachim Diebold(University of Lucerne), Elisabeth Bloemena(Amsterdam Neuroscience), Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), Dominique Wendum(Sorbonne Université), Joanne Verheij, Emmanuelle Leteurtre(Université de Lille), Chris J. Mulder(Amsterdam University Medical Centers), Pieter E. Zondervan(Erasmus MC), A. Mieke Jonker(Refaja Ziekenhuis), Nanne K.H. de Boer, Fritz Wrba(University of Vienna)
Cited by 60
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k